Matthew regularly assists life sciences clients and other technology-driven enterprises, including companies in the emerging biotech and medical device sectors. His experience is broad, advising issuers, investors and dealers in public and private corporate finance transactions such as venture capital financings, private placements and public offerings, including IPOs. Clients ranging from established public issuers to technology start-ups also seek Matthew’s advice on ongoing Canadian corporate and securities law matters.

Matthew’s transactional work for clients also includes working with acquirers and targets undertaking public or private M&A transactions, including share acquisitions, plans of arrangement and other business combinations. He is also experienced helping life sciences clients with the full spectrum of their commercial agreements, including IP licensing transactions, distribution arrangements, and research and collaboration agreements.